Document Detail


The risks and benefits of early immunosuppression and biological therapy.
MedLine Citation:
PMID:  23295699     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Crohn's disease and ulcerative colitis are heterogeneous conditions with highly variable courses of disease. Recent studies have focused on the time soon after diagnosis as a potential window of opportunity before which complicated disease behaviors have ensued and in which attaining adequate control of the inflammatory process might improve long-term outcomes. This review covers the use of immune suppression and biological therapy early in the course of inflammatory bowel disease. It includes the rationale for using these medications earlier, the features of early disease that may lead to improved outcomes with early intervention, the most optimal strategies for early treatment, the benefits of early intervention and the risks of this approach. In addition, we discuss the issue of which patients to choose for early intervention through risk stratification.
Authors:
Bruce E Sands
Related Documents :
23695429 - Inflammatory bowel disease epidemiology.
21460639 - Successful treatment of asymptomatic or clinically terminal bovine mycobacterium avium ...
24394559 - Feasibility of a web-based survey of hallucinations and assessment of visual function i...
21233269 - The role of matrix metalloproteinases in cystic fibrosis lung disease.
25104399 - Ipsc technology- powerful hand for disease modeling and therapeutic screen.
21207519 - Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from ...
7647219 - The clinical value of tissue factor assays.
11105129 - Antimicrobial susceptibility of klebsiella pneumoniae producing extended-spectrum beta-...
17301649 - Crohn's disease and polymorphism of heat shock protein gene hsp70-2 in the tunisian pop...
Publication Detail:
Type:  Journal Article     Date:  2013-01-03
Journal Detail:
Title:  Digestive diseases (Basel, Switzerland)     Volume:  30 Suppl 3     ISSN:  1421-9875     ISO Abbreviation:  Dig Dis     Publication Date:  2012  
Date Detail:
Created Date:  2013-01-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8701186     Medline TA:  Dig Dis     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  100-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 S. Karger AG, Basel.
Affiliation:
The Dr. Henry D. Janowitz Division of Gastroenterology, Mount Sinai School of Medicine, New York, N.Y., USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Topical therapy.
Next Document:  Deep remission: a new concept?.